Zentek Limited (ZTEK) - מכפיל מחיר להכנסות עתידי

The forward P/S ratio reflects the expected sales dynamics of graphene materials and security systems for plants, where the value 779.70 serves as the baseline indicator. Business resilience is driven by the integration of nano-coatings into filters and masks, which mitigates industry risks. The high authority of Zentek Ltd. (ZTEK) as the developer of ZenGUARD confirms its technological superiority and growing trust among medical professionals.

Identifying a fundamental floor for Zentek Ltd. (ZTEK) requires analyzing the ratio of current market capitalization to projected revenue from the expansion of nano-coatings in medicine. The expected P/S ratio reflects the market valuation of future cash flows, allowing investors to determine the extent to which the share price is outpacing the scaling of production and the execution of B2B contracts, which is critical for assessing the reliability of this high-tech asset.